Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

A novel class of parenteral anticoagulant agents for percutaneous coronary intervention (PCI) based on tick thrombin inhibitors

6th European Biopharma Congress

R Manjunatha Kini

National University of Singapore, Singapore

Posters & Accepted Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X-C1-029

Abstract
Hematophagous insects depend on potent anticoagulant and antiplatelet agents for securing their blood meals. We identified a novel class of thrombin inhibitors, named as ixothrins, from the salivary gland extracts of ticks. We isolated and characterized variegin and avathrin from the salivary gland extracts of tropical bont tick (Amblyomma variegatum). They are among the smallest thrombin inhibitors found in nature. We examined the structure-function relationships of variegin, avathrin and ultravariegin using a number of mutants. We also determined the X-ray crystal structure of thrombin-variegin and thrombin-avathrin complexes. They interact with exosite I, prime subsites and active site of thrombin. Based on the structure as well as the prior knowledge on thrombin inhibitors, we designed several peptides to understand the interaction between thrombin and these inhibitors. These peptides cover a diverse spectrum of potency, kinetics and mechanism of inhibition, including peptides with affinities ranging from low picomolar to nanomolar values, with fast and slow tight binding, displaying competitive and non-competitive inhibition. We evaluated the antithrombotic efficacy (carotid artery thrombosis and stent thrombosis models) and bleeding side effects (tail incision and ear bleeding models) of variegin in rats and pigs, respectively. The results strongly support the superior antithrombotic efficacy of variegin with minimal bleeding in comparison with comparator drugs, heparin and hirulog (Bivaluridin or Angiomax®). Thus, ixothrins may have the potential in developing parenteral anticoagulant agents for percutaneous coronary intervention (PCI).
Biography

E-mail: dbskinim@nus.edu.sg

 

Top